Your browser doesn't support javascript.
loading
Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia.
Ogyu, Kamiyu; Noda, Yoshihiro; Yoshida, Kazunari; Kurose, Shin; Masuda, Fumi; Mimura, Yu; Nishida, Hana; Plitman, Eric; Tarumi, Ryosuke; Tsugawa, Sakiko; Wada, Masataka; Miyazaki, Takahiro; Uchida, Hiroyuki; Graff-Guerrero, Ariel; Mimura, Masaru; Nakajima, Shinichiro.
Afiliação
  • Ogyu K; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Noda Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Yoshida K; Pharmacogenetic Research Clinic, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Kurose S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Masuda F; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Mimura Y; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Nishida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Plitman E; Cerebral Imaging Centre, Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
  • Tarumi R; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Tsugawa S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Wada M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Miyazaki T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Graff-Guerrero A; Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada.
  • Mimura M; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Nakajima S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Neuropsychopharmacol Rep ; 40(2): 138-149, 2020 06.
Article em En | MEDLINE | ID: mdl-32180369
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Psicologia do Esquizofrênico / Antipsicóticos / Dibenzocicloeptenos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Neuropsychopharmacol Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Psicologia do Esquizofrênico / Antipsicóticos / Dibenzocicloeptenos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Neuropsychopharmacol Rep Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão